Home › MolMed TK therapy submitted for Conditional Marketing Authorisation in EU
 

Keywords :   


MolMed TK therapy submitted for Conditional Marketing Authorisation in EU

2014-03-13 21:03:04| Logistics - Topix.net

MolMed S.p.A. announces that the Company has filed to the European Medicines Agency an application for Conditional Marketing Authorisation for TK, its novel investigational cell-gene therapy.

Tags: in marketing submitted therapy

Category:Transportation and Logistics

Latest from this category

All news
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
Transportation and Logistics »
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »